Testing enzymes in ACE-inhibitor–related facial swelling
Part of Immune system & allergy clinical trials.
This trial studies what happens in the body’s enzyme system in people who get facial swelling (angioedema) from certain blood pressure medicines called ACE inhibitors. The goal is to better understand the cause and potentially guide safer treatment for future episodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your swelling happened because of an ACE inhibitor medicine and started within the last 15 days
- Alternatively, you have an isolated swelling episode (without surface hives) that lasts at least 15 hours
- Your diagnosis is confirmed by an expert team
- You can sign consent and are covered by social security
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a blood test measuring C1-inhibitor function can help diagnose hereditary angioedema (HAE), a rare condition that causes painful swelling episodes. If you or a close family member have had swelling without rash or itching that lasts 1-5 days and doesn't get better with allergy meds, this trial may be for you.
This study collects blood samples (and optional skin samples) from people with angioedema to learn more about the condition and find better ways to diagnose and treat it. If you join, you may help scientists understand angioedema better.
This study looks at the genes that cause hereditary angioedema (HAE), a condition with sudden swelling in the hands, feet, face, or airways. By joining, you help doctors understand the disease better, which could lead to better care for you and others.
This study tests an oral medication that can be taken daily to prevent angioedema attacks and as a rescue treatment when attacks occur. It may help reduce the frequency and severity of swelling episodes.
This trial tests a plasma-derived C1 esterase inhibitor to treat and prevent acute attacks in people with hereditary angioedema (HAE) types 1 or 2. It aims to see if the medicine can quickly relieve swelling episodes and reduce their frequency.
This trial tests if sebetralstat can prevent swelling attacks before medical procedures in people with HAE types I or II. You take the medicine short-term before your procedure to see if it helps protect you from an attack.
Hear when a new Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.